236 related articles for article (PubMed ID: 18375131)
1. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
Kamiński K; Obniska J
Bioorg Med Chem; 2008 May; 16(9):4921-31. PubMed ID: 18375131
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
Kamiński K; Rzepka S; Obniska J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5800-3. PubMed ID: 21875804
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticonvulsant properties of new Mannich bases derived from 3-aryl-pyrrolidine-2,5-diones. Part 1.
Obniska J; Kopytko M; Zagórska A; Chlebek I; Kamiński K
Arch Pharm (Weinheim); 2010 Jun; 343(6):333-41. PubMed ID: 20379970
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II.
Obniska J; Rzepka S; Kamiński K
Bioorg Med Chem; 2012 Aug; 20(15):4872-80. PubMed ID: 22717240
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticonvulsant activity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 3-phenyl-pyrrolidine-2,5-dione.
Obniska J; Kaminski K; Skrzynska D; Pichor J
Eur J Med Chem; 2009 May; 44(5):2224-33. PubMed ID: 18603334
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticonvulsant activity of 1-(8-(benzyloxy)quinolin-2-yl)-6-substituted-4,6-diazaspiro[2,4]heptane-5,7-diones.
He X; Zhong M; Zhang T; Yang J; Wu Z; Xiao Y; Guo H; Qiu G; Hu X
Eur J Med Chem; 2012 Feb; 48():338-46. PubMed ID: 22236471
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticonvulsant activity of new 6-methyl-1-substituted-4,6-diazaspiro[2.4]heptane-5,7-diones.
He X; Qiu G; Yang J; Xiao Y; Wu Z; Qiu G; Hu X
Eur J Med Chem; 2010 Sep; 45(9):3818-30. PubMed ID: 20542603
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones.
Obniska J; Chlebek I; Pichór J; Kopytko M; Kamiński K
Acta Pol Pharm; 2009; 66(6):639-47. PubMed ID: 20050528
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticonvulsant properties of new mannich bases derived from 3,3-disubstituted pyrrolidine-2,5-diones. Part IV.
Obniska J; Chlebek I; Kamiński K
Arch Pharm (Weinheim); 2012 Sep; 345(9):713-22. PubMed ID: 22674811
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticonvulsant activity of new spirosuccinimides differently substituted at the imide nitrogen atom.
Obniska J; Kamiński K; Chlebek I
Acta Pol Pharm; 2009; 66(6):663-9. PubMed ID: 20050530
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5-phenyl-hydantoins.
Byrtus H; Obniska J; Czopek A; Kamiński K
Arch Pharm (Weinheim); 2011 Apr; 344(4):231-41. PubMed ID: 21469172
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of anticonvulsant activity of pyridinyl-pyrrolidones: a pharmacophore hybrid approach.
Siddiqui N; Ahsan W; Alam MS; Ali R; Srivastava K
Arch Pharm (Weinheim); 2012 Mar; 345(3):185-94. PubMed ID: 21997797
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticonvulsant activity of 1-(2-(8-(benzyloxy)quinolin-2-yl)-1-butyrylcyclopropyl)-3-substituted urea derivatives.
He X; Zhong M; Yang J; Wu Z; Xiao Y; Guo H; Hu X
Chem Biol Drug Des; 2012 May; 79(5):771-9. PubMed ID: 22304806
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticonvulsant activity of ethyl 1-(2-arylhydrazinecarboxamido)-2,2-dimethylcyclopropanecarboxylate derivatives.
He X; Zhong M; Zhang T; Wu W; Wu Z; Xiao Y; Hu X
Eur J Med Chem; 2012 Aug; 54():542-8. PubMed ID: 22727446
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)- 3-substituted pyrrolidine-2,5-dione derivatives.
Kamiński K; Obniska J
Acta Pol Pharm; 2008; 65(4):457-65. PubMed ID: 19051587
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and anticonvulsant activity of new N-Mannich bases derived from spirosuccinimides and spirohydantoins.
Obniska J; Byrtus H; Kamiński K; Pawłowski M; Szczesio M; Karolak-Wojciechowska J
Bioorg Med Chem; 2010 Aug; 18(16):6134-42. PubMed ID: 20638856
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant activity of some xanthone derivatives.
Marona H; Pekala E; Antkiewicz-Michaluk L; Walczak M; Szneler E
Bioorg Med Chem; 2008 Aug; 16(15):7234-44. PubMed ID: 18640843
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticonvulsant activity of new N-Mannich bases derived from 5-cyclopropyl-5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-imidazolidine-2,4-diones.
Byrtus H; Obniska J; Czopek A; Kamiński K; Pawłowski M
Bioorg Med Chem; 2011 Oct; 19(20):6149-56. PubMed ID: 21917466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
